You are here

Article Text

Article menu
Download PDFPDF
Research Article
The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy.
  1. J H Coakley,
  2. J Moorcraft,
  3. L J Hipkin,
  4. C S Smith,
  5. R D Griffiths,
  6. R H Edwards
  1. University Department of Medicine, Royal Liverpool Hospital, UK.

    Abstract

    Mazindol has been reported to improve muscle function in Duchenne muscular dystrophy (DMD) by virtue of its growth hormone (GH) suppression. The effects were studied on GH secretion (in response to growth hormone releasing factor and sleep) of mazindol 2 mg daily for 3 months in five boys with DMD. No consistent change was found following mazindol therapy. Adverse effects were noted in all the boys which may preclude long term use of mazindol in DMD.

    https://doi.org/10.1136/jnnp.51.12.1551

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.